{"id":50807,"date":"2021-08-11T09:56:45","date_gmt":"2021-08-11T08:56:45","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=50807"},"modified":"2021-08-12T15:56:32","modified_gmt":"2021-08-12T14:56:32","slug":"data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/","title":{"rendered":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value"},"content":{"rendered":"<p><i><span style=\"font-weight: 400\">Mark Lawler, Chris Carrigan, and colleagues describe how DATA-CAN\u2019s<\/span><\/i> <i><span style=\"font-weight: 400\">co-created partnership has brought together patient representatives, healthcare professionals, and academic and industry researchers to <\/span><\/i><i><span style=\"font-weight: 400\">facilitate responsible collection and use of big data\u00a0<\/span><\/i><\/p>\n<p><b>Mark Lawler, scientific director, DATA-CAN;<\/b><b> Charlie Davie, hub director, DATA-CAN; Chris Carrigan, patient and public involvement and engagement (PPIE) lead, DATA-CAN (pictured left to right)<\/b><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-50815\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1.jpg\" alt=\"\" width=\"592\" height=\"236\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1.jpg 1503w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1-300x120.jpg 300w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1-1024x408.jpg 1024w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1-768x306.jpg 768w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_1-640x255.jpg 640w\" sizes=\"auto, (max-width: 592px) 100vw, 592px\" \/><\/p>\n<p><span style=\"font-weight: 400\">Large datasets that are responsibly and transparently handled offer great potential to accelerate discoveries that lead to better prevention, earlier diagnosis, and innovative treatments for many diseases\u2014not least cancer. To reap the benefits, however, full transparency and responsible use of data is essential to allay public concerns about<\/span> <span style=\"font-weight: 400\">privacy and inappropriate use of personal health information.<\/span><\/p>\n<p><span style=\"font-weight: 400\">DATA-CAN, the <a href=\"https:\/\/www.data-can.org.uk\/\">UKs Health Data Research Hub for Cancer<\/a><\/span><span style=\"font-weight: 400\">, <\/span><span style=\"font-weight: 400\">was created <\/span><span style=\"font-weight: 400\">to break down silos between the many different sources of cancer intelligence, and instead collate them to drive better research<\/span> <span style=\"font-weight: 400\">and deliver greater<\/span> <span style=\"font-weight: 400\">individual<\/span> <span style=\"font-weight: 400\">and societal benefits. We<\/span><span style=\"font-weight: 400\"> defined a roadmap and key principles, agreed jointly with patients, health professionals, and academic\/industry researcher partners, to maximise trust in the use of cancer data<\/span><span style=\"font-weight: 400\">.<sup>1 2<\/sup><\/span><\/p>\n<p><span style=\"font-weight: 400\">With the emergence of<\/span> <span style=\"font-weight: 400\">covid-19 in January 2020, DATA-CAN rapidly pivoted <\/span><span style=\"font-weight: 400\">from an overarching cancer data agenda <\/span><span style=\"font-weight: 400\">to focus on addressing the pandemic\u2019s effect on cancer services and<\/span> <span style=\"font-weight: 400\">patients with cancer, <a href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/05\/11\/cancer-must-not-be-the-forgotten-c-in-the-fight-against-covid-19\/\">delivering valuable research findings<\/a><\/span><span style=\"font-weight: 400\"> that were<\/span><span style=\"font-weight: 400\">\u00a0<\/span><span style=\"font-weight: 400\">recognised with <a href=\"https:\/\/www.data-can.org.uk\/latest\/cancer-data-project-on-the-impact-of-covid-19-wins-major-uk-award-1\">a prestigious award<\/a><\/span><span style=\"font-weight: 400\">. At the European level, this work has underpinned the <a href=\"https:\/\/cancerworld.net\/building-back-cancer-services-after-covid-19-european-cancer-organisation-plan\/\">European Cancer Organisation\u2019s 7-point plan<\/a><\/span><span style=\"font-weight: 400\"> and <a href=\"https:\/\/www.europeancancer.org\/TimeToAct\">Time To Act<\/a><\/span><span style=\"font-weight: 400\">, campaigns that are working to mitigate the impact of covid-19 on patients with cancer and cancer services.\u00a0<\/span><\/p>\n<p><b><i>How DATA-CAN works with patients and the public<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400\">DATA-CAN <a href=\"https:\/\/www.data-can.org.uk\/patients\">works directly with patients, relatives, and carers<\/a> to bring their voices to complex conversations about data and participation in research<\/span><span style=\"font-weight: 400\">. DATA-CAN recognised from the outset that<\/span><span style=\"font-weight: 400\"> to be confident to voice their views and concerns at all levels, patient and public partners need to be empowered. Two voting PPIE members sit on DATA-CAN\u2019s <a href=\"https:\/\/www.data-can.org.uk\/steering-board\">steering board<\/a><\/span><span style=\"font-weight: 400\">, making them more influential than any other individual DATA-CAN partner (who each have a single representative). Additionally, two PPIE members sit on DATA-CAN\u2019s <a href=\"https:\/\/www.data-can.org.uk\/management-group\">management group<\/a><\/span><span style=\"font-weight: 400\">, while <\/span><span style=\"font-weight: 400\">DATA-CAN&#8217;s budget (around 10% for PPIE activities) and action plan reflect the key role and responsibility of its patient and public partners. Their empowerment has been promoted by asking an initial three PPIE members, chosen based on their expertise and previous working with DATA-CAN members, to set the agenda for the wider number of PPIE members (see below) who have been invited to participate in specific working groups within DATA-CAN\u2019s different workstreams on areas such as covid-19, trusted research environments, commercial involvement, training, etc.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Our approach has been to trust our PPIE members to self-organise and lead lay involvement and we have found that they have delivered on this trust. No expectation is set on patients\u2019 time commitment\u2014we worked on the basis that the average commitment would be two to three hours per calendar month. In practice, some of the patients and carers commit significantly more time, depending on their work, voluntary, and family commitments. Remuneration is by honoraria, aligned with <a href=\"https:\/\/www.invo.org.uk\/wp-content\/uploads\/2016\/05\/INVOLVE-internal-payment-policy-2016-final-1.pdf\">INVOLVE guidelines<\/a><\/span><span style=\"font-weight: 400\">; travel and other expenses are also reimbursed.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Our PPIE group members review, approve, and have the right to veto any DATA-CAN proposal or contract. <\/span><span style=\"font-weight: 400\">In one instance, our PPIE group objected to a particular commercial company\u2019s proposed terms. They also successfully lobbied for the inclusion of equality, diversity, and inclusion assessments in proposals<\/span> <span style=\"font-weight: 400\">and a commitment to share clinical insights. Additionally, they challenged DATA-CAN\u2019s leadership to commit to a project on triple-negative breast cancer, which we initially thought that we didn\u2019t have time to deliver. Their passion and reasoned arguments on the project\u2019s positive<\/span><span style=\"font-weight: 400\"> impact for patients <a href=\"https:\/\/eur02.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.data-can.org.uk%2Fusing-data-to-improve-treatment-options-for-early-triple-negative-breast-cancer&amp;data=04%7C01%7Cmark.lawler%40qub.ac.uk%7C3f422369ae5d4ec6f9c708d947a4c0ae%7Ceaab77eab4a549e3a1e8d6dd23a1f286%7C0%7C0%7C637619596140161545%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C2000&amp;sdata=3RMgWv0GRei5BhUZSp1jzRPGW%2F9Q6hV5nHnqz4j3gZU%3D&amp;reserved=0\">persuaded us<\/a> it was worth the risk<\/span><span style=\"font-weight: 400\">.\u00a0<\/span><\/p>\n<p><b>Pete Wheatstone and Jacqui Gath, cancer survivors and respectively chair and <\/b><b>member of the PPIE subgroup (pictured left to right)<\/b><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-50816\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_2.jpg\" alt=\"\" width=\"402\" height=\"236\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_2.jpg 366w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_2-300x176.jpg 300w\" sizes=\"auto, (max-width: 402px) 100vw, 402px\" \/><\/p>\n<p><span style=\"font-weight: 400\">DATA-CAN\u2019s approach to PPIE is radically different from our previous experience as patient advocates. From the outset we were supported, invited, and empowered\u00a0 to participate in all discussions on the project&#8217;s direction and operation\u2014rather than being asked to give a view post hoc without previous involvement in the project. This required courage from DATA-CAN and confidence in the contributions and decisions of our PPIE <\/span><span style=\"font-weight: 400\">group. It has also required bravery, determination, and hard work from us to judiciously and democratically represent the interests of all patients.<\/span><\/p>\n<p><span style=\"font-weight: 400\">We helped draft early versions of the initial successful grant application that led to DATA-CAN\u2019s establishment and helped draw up its strategy. We also <\/span><span style=\"font-weight: 400\">made suggestions to DATA-CAN\u2019s partnership agreement that were adopted, and co-designed PPIE role specifications\/PPIE group terms of reference. We sat on DATA-CAN interview panels for senior positions (such as chief operating officer).\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">PPIE members were selected via an \u201cexpression of interest,\u201d advertised through a network of organisations\/patient groups using newsletters, social media, and <a href=\"https:\/\/www.peopleinresearch.org\">https:\/\/www.peopleinresearch.org<\/a>, which included questions about what attracted them to the role and what they felt they could contribute. Once members were selected, we established informal \u201ddiscussion fora&#8221; to assess people&#8217;s ability to listen, speak, and collaborate proactively. Candidates were selected on these qualities and their life experience as patients or carers. We also selected people to represent diversity in terms of being a patient or carer; ethnicity; cancer type; age; geography; PPIE experience; work background. Lay members were drawn from all walks of life, commercial and public, from hauliers to hospital staff. A key responsibility of PPIE members is to harness widely held viewpoints and this was built into role specifications and evaluated at discussion fora. Through our 13 PPIE core members, we engage with a group of over 100 organisations, which is constantly growing in number and diversity.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">PPIE members identified a range of themes where they felt that they, or other patients with cancer or cancer survivors, needed<\/span><span style=\"font-weight: 400\">\u00a0greater knowledge, including <\/span><span style=\"font-weight: 400\">legal aspects, international data comparisons, research access to data, and commercial uses of data.<\/span><span style=\"font-weight: 400\"> To address this, we have run nearly 20 drop-in sessions online that take place fortnightly or two weekly and which<\/span> <span style=\"font-weight: 400\">cover each topic in turn, comprising a briefing pack, a presentation from an expert on the topic, and an open Q&amp;A.\u00a0All sessions are recorded, forming part of <a href=\"https:\/\/www.data-can.org.uk\/patient-and-public-educational-programme\">a learning resource for members<\/a><\/span><span style=\"font-weight: 400\">.\u00a0<\/span><span style=\"font-weight: 400\">We also deliver one-on-one training where required.<\/span><\/p>\n<p><span style=\"font-weight: 400\">During the pandemic, the inability to meet face to face has slowed the establishment of working relations and some PPIE members required support to obtain and use IT equipment. We therefore had to put in more time than expected (up to around 20-25 hours a month) to enable us to take on a range of activities including <a href=\"https:\/\/www.data-can.org.uk\/patient-benefits\">co-creating case studies<\/a><\/span><span style=\"font-weight: 400\">, writing <a href=\"https:\/\/www.data-can.org.uk\/latest\/gp-data-access-a-cancer-patients-view\">blogs<\/a><\/span><span style=\"font-weight: 400\">, chairing webinars, and co-authoring scientific papers. But we have been pleased to put in this time, as the value of our input and the trust placed in us by our academic and research colleagues has been hugely rewarding. Our involvement in DATA-CAN reflects our interest in ensuring that data is used to improve human health; together, we bring over 30 years of experience in PPIE. Many DATA-CAN PPIE members want to contribute beyond providing their lived experience of cancer and its impacts on their lives.\u00a0\u00a0\u00a0<\/span><\/p>\n<p><b>James Peach,<\/b> <b>commercial director, DATA-CAN; Yoshiko Cook, DATA-CAN programme director for IQVIA<\/b><b>; Arun Sujenthiran,<\/b><b> clinical<\/b> <b>lead, Flatiron Health UK (pictured left to right)<\/b><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-50817 \" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_3.jpg\" alt=\"\" width=\"596\" height=\"236\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_3.jpg 553w, https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/ppe_group_3-300x119.jpg 300w\" sizes=\"auto, (max-width: 596px) 100vw, 596px\" \/><\/p>\n<p><span style=\"font-weight: 400\">The experience of <a href=\"https:\/\/www.bmj.com\/content\/354\/bmj.i3636\">care.data<\/a><\/span><span style=\"font-weight: 400\">, <a href=\"https:\/\/www.data-can.org.uk\/latest\/gp-data-access-a-cancer-patients-view\">General Practice Data for Planning and Research<\/a><\/span><span style=\"font-weight: 400\">,<\/span><span style=\"font-weight: 400\"> and the concerns raised by patients and the public about commercial access to NHS data make it vital to involve patients in decisions about use of their data. Organisations using or seeking to use patient data also need to give people the full picture and respond to what they say.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">To promote effective partnership in decision making in relation to commercial activities, DATA-CAN gives patient representatives appropriate training (see above) and payment for their time. Initiatives such as <a href=\"http:\/\/www.iqvia.com\/locations\/united-kingdom\/solutions\/cancer-data-network\">IQVIA\u2019s Cancer Data Network<\/a>, developed to support DATA-CAN, <\/span><span style=\"font-weight: 400\">involved PPIE members early on so that they<\/span> <span style=\"font-weight: 400\">provided<\/span> <span style=\"font-weight: 400\">critical input to the network\u2019s vision, technology, information governance, and privacy, holding IQVIA accountable to ensure they offer fair value to patients and NHS stakeholders.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Flatiron Health, <\/span><span style=\"font-weight: 400\">a company that<\/span> <span style=\"font-weight: 400\">uses real world oncology data <a href=\"https:\/\/flatiron.com\/values\/\">to improve patient outcomes<\/a>,<\/span><span style=\"font-weight: 400\">\u00a0<\/span><span style=\"font-weight: 400\">opened a dialogue with DATA-CAN through which PPIE members learnt about, provided feedback, and <a href=\"https:\/\/eur02.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.data-can.org.uk%2Fdata-can-industry-partnership-flatiron-health-connects-with-patients&amp;data=04%7C01%7Cmark.lawler%40qub.ac.uk%7Cf1ad49610eb64baa873308d94123eaee%7Ceaab77eab4a549e3a1e8d6dd23a1f286%7C0%7C0%7C637612445849456649%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C2000&amp;sdata=BEyiT7PnZ8mL7%2Fg2heA2%2FB1AClwZV10YSb%2FEXFKQQro%3D&amp;reserved=0\">evaluated Flatiron\u2019s \u201cvalue propositions\u201d on cancer data<\/a><\/span><span style=\"font-weight: 400\">. Patient voices have shaped and strengthened Flatiron\u2019s approach; and in direct response to patient feedback, Flatiron launched its own patient board, which is embedded in internal decisions and external communication activities.<\/span><span style=\"font-weight: 400\">\u00a0<\/span><\/p>\n<p><b>Key<\/b> <b>messages<\/b> <b>\u00a0<\/b><b><i>\u00a0<\/i><\/b><\/p>\n<ol>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Time, effort, and appropriate remuneration is needed to embed meaningful patient and public<\/span> <span style=\"font-weight: 400\">involvement in health data research and its translation to practice and policy.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Ensuring PPIE members are and feel empowered is important to ensure they contribute fully as equals.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Involving patient representatives in discussions with commercial companies is key to improving the quality, transparency, and patient-centricity of research proposals\/activities.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Co-creation of projects by all stakeholders is essential to deliver fair value to patients, health services, academia, and industry.<\/span><\/li>\n<\/ol>\n<p><b>Future directions<\/b><\/p>\n<p><span style=\"font-weight: 400\">We are currently reaching out to patient groups to create a \u201cnetwork of networks\u201d and planning for cancer data \u201ccitizen juries\u201d across the four UK nations. <\/span><span style=\"font-weight: 400\">We have extended our &#8220;drop-in &#8220;programme to include patient members from the <a href=\"https:\/\/www.ncri.org.uk\/how-we-work\/patients-carers\/ncri-consumer-forum\/\">National Cancer Research Institute Consumer Forum<\/a><\/span><span style=\"font-weight: 400\"> and <a href=\"http:\/\/www.usemydata.org.uk\/\">use MY data<\/a> advisory group members<\/span>\u00a0<span style=\"font-weight: 400\">to widen our base. We are also setting up a programme to promote \u201cfairness\u201d for underserved groups, particularly<\/span> <span style=\"font-weight: 400\">minority ethnic groups, in an effort to find a way to reduce the increased mortality and morbidity associated with covid-19 in men of certain ethnicities. We also seek to redress <a href=\"https:\/\/uclpartners.com\/blog-post\/fairness-the-importance-of-diversity-in-health-data-for-creating-better-fairer-treatment-for-all\/\">the gender imbalance<\/a>, which has seen women disadvantaged by lack of data about their symptoms, response to drugs, and treatment side effects.<\/span><span style=\"font-weight: 400\">\u00a0<\/span><\/p>\n<p><em><b>Pete Wheatstone,<\/b><span style=\"font-weight: 400\"> cancer<\/span> <span style=\"font-weight: 400\">survivor and chair, PPIE group, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Jacqui Gath,<\/b><span style=\"font-weight: 400\"> cancer survivor and PPIE group member, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Chris Carrigan,<\/b><span style=\"font-weight: 400\"> PPIE lead and chief operating officer, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Geoff Hall,<\/b><span style=\"font-weight: 400\"> clinical lead, DATA-CAN\u00a0<\/span><\/em><\/p>\n<p><em><b>Yoshiko Cook, <\/b><span style=\"font-weight: 400\">DATA-CAN programme director<\/span><span style=\"font-weight: 400\"> IQVIA; commercial lead, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Arun Sujenthiran<\/b><b>, <\/b>m<span style=\"font-weight: 400\">edical director and clinical lead, Flatiron Health UK<\/span><\/em><\/p>\n<p><em><b>James Peach,<\/b><span style=\"font-weight: 400\"> commercial director, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Charlie Davie, <\/b><span style=\"font-weight: 400\">hub director, DATA-CAN<\/span><\/em><\/p>\n<p><em><b>Mark Lawler,<\/b><span style=\"font-weight: 400\"> scientific director, DATA-CAN<\/span><\/em><\/p>\n<p><b>Contributors<\/b><\/p>\n<p><span style=\"font-weight: 400\">Pete Wheatstone is chair of DATA-CAN\u2019s PPIE group and is also a member of DATA-CAN\u2019s steering board. He is a bowel cancer survivor and has developed significant expertise in data during a 20 year IT career with IBM UK and his own IT companies. Jacqui Gath is a member of the DATA-CAN PPIE group. She is a breast cancer survivor. Jacqui\u2019s previous role in IT at a major financial institution provides a good understanding of the principles and practice of data science. Chris Carrigan is <\/span><span style=\"font-weight: 400\">PPIE lead and interim chief operating officer of DATA-CAN. He has <\/span><span style=\"font-weight: 400\">a background in health data, informatics, cancer, and patient advocacy. Geoff Hall is the clinical lead for DATA-CAN, professor of digital health and cancer medicine at the University of Leeds, and an honorary consultant in medical oncology at the Leeds Cancer Centre. Yoshiko Cook is commercial lead for DATA-CAN and DATA-CAN programme director for IQVIA<\/span><span style=\"font-weight: 400\">. Arun Sujenthiran<\/span><span style=\"font-weight: 400\"> is medical director and clinical lead, Flatiron Health UK. James Peach is the commercial director of DATA-CAN, with extensive experience advising public bodies, industry organisations, pharmaceutical companies, and startups on genomics and data in healthcare. Charlie Davie is DATA-CAN\u2019s hub director. He is a practising consultant neurologist at the Royal Free London NHS Foundation Trust.\u00a0Mark Lawler is DATA-CAN\u2019s scientific director. He is associate pro-vice-chancellor, professor of digital health, and chair in translational cancer genomics at Queen&#8217;s University Belfast, UK.<\/span><\/p>\n<p><span style=\"font-weight: 400\">We encourage organisations to adopt the Patient Data Citation, developed by the patient, relatives, and carer members of use MY data:<\/span><\/p>\n<p><i><span style=\"font-weight: 400\">&#8220;This work uses data provided by patients and collected by the NHS as part of their care and support&#8221;<\/span><\/i><\/p>\n<p><b>Competing Interests<\/b><\/p>\n<p><span style=\"font-weight: 400\">PW none; JG none; CC has received honoraria from Carnall Farrar unrelated to this work. GH has received honoraria from IQVIA to support their Cancer Data Network; YC is an employee of IQVIA;\u00a0 AS is an employee of Flatiron Health Inc, an independent subsidiary of Roche, and holds stock in Roche; JP has been a consultant to Health Data Research UK, Association of British Pharmaceutical Industry, Roche, Novartis, Sensyne Health, IQVIA, and Mendelian in the past three<\/span> <span style=\"font-weight: 400\">years and is a current director of Precision Strategy, Univ8 Genomics, and Human Centric Drug Discovery; <\/span><span style=\"font-weight: 400\">CD has received an honorarium from Merck group for unrelated work;<\/span><span style=\"font-weight: 400\"> ML has received an unrestricted educational grant from Pfizer for research unrelated to this work. ML has received honoraria from Pfizer, EMD Serono, Roche, and Carnall Farrar unrelated to this work\u00a0<\/span><\/p>\n<p><b>Acknowledgements<\/b><\/p>\n<p><span style=\"font-weight: 400\">We thank <\/span><span style=\"font-weight: 400\">Joanna Clason, head of communications, DATA-CAN<\/span><span style=\"font-weight: 400\"> for her reading of the manuscript and for ensuring that public<\/span> <span style=\"font-weight: 400\">facing versions of the case studies are available on DATA-CAN\u2019s website. We acknowledge the additional members of the DATA-CAN PPIE group (Alison Allam, Yvonne Adebola, Naomi Asantewa, John Barnes, Libby Cooper, Janet Frost, Margaret Grayson, Jo Gumbs, Steven Hill, Maisie McKenzie, and Sue Trant) and the remaining members of the DATA-CAN Management Group (Prabhu Arumugam, genomics lead, DATA-CAN;<\/span> <span style=\"font-weight: 400\">Amanda Begley, director of innovation and implementation, UCLPartners; <\/span><span style=\"font-weight: 400\">Jessica Catone, project manager, DATA-CAN; Willie Hamilton, professor of primary care diagnostics, University of Exeter; Peter Hall, reader in cancer informatics and health economics, University of Edinburgh; Monica Jones, chief data officer, DATA-CAN; Kathy Pritchard-Jones, clinical lead, DATA-CAN; Yeen Tran, business and finance manager, DATA-CAN).\u00a0<\/span><\/p>\n<p><b>References<\/b><\/p>\n<ol>\n<li><span style=\"font-weight: 400\"> Lawler M, Morris AD, Sullivan R, Birney E, Middleton A, Makaroff L, Knoppers BM, Horgan D, Eggermont A. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30102210\/\"><span style=\"font-weight: 400\">A roadmap for restoring trust in Big Data. <\/span><\/a><i><span style=\"font-weight: 400\">Lancet Oncol<\/span><\/i><span style=\"font-weight: 400\">. 2018; 19:1014-1015.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400\"> Lawler M, Haussler D, Siu LL, Haendel MA, McMurry JA, Knoppers BM, Chanock SJ, Calvo F, The BT, Walia G, Banks I, Yu PP, Staudt LM, Sawyers CL. Clinical Cancer Genome Task Team of the Global Alliance for Genomics and Health <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28538124\/\"><span style=\"font-weight: 400\">Sharing Clinical and Genomic Data on Cancer &#8211; The Need for Global Solutions. <\/span><\/a><i><span style=\"font-weight: 400\">N Engl J Med. <\/span><\/i><span style=\"font-weight: 400\">2017; 376:2006-2009.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400\">Sud A, Torr B, Loveday C, Jones M, Broggio\u00a0 J,\u00a0 Scott S, Gronthoud F, Nicol DL, Garrett A, Jhanji S, Boyce SA, Williams M, Lyratzopoulos G, Barry C, Riboli E, Kipps E, Larkin Navani N, Swanton C, McFerran E, Muller DC, Lawler M,<\/span> <span style=\"font-weight: 400\">Houlston R, Turnbull C. <\/span><span style=\"font-weight: 400\">COVID-19 Lockdown and its impact on the two-week wait pathway for suspected cancer. <\/span><i><span style=\"font-weight: 400\">Lancet Oncol <\/span><\/i><span style=\"font-weight: 400\">2020; 21:1035-1044.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400\"> Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH, Katsoulis M, Williams B, Pillay D, Noursadeghi M, Linch D, Hughes D, Forster D, Turnbull C, Fitzpatrick NK, <\/span><span style=\"font-weight: 400\">Boyd K, <\/span><span style=\"font-weight: 400\">Foster GR, Enver T, DATA-CAN, Cooper M, Jones M, Pritchard-Jones K, Sullivan R, Davie C, Lawler M, Hemingway H. Estimated impact of the Covid-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near-real-time data on cancer care, cancer deaths and a population-based cohort study. <\/span><i><span style=\"font-weight: 400\">BMJ Open<\/span><\/i><span style=\"font-weight: 400\">. 2020;10:e043828.<\/span><\/li>\n<li>Ho KMA, Banerjee A, Lawler M, Rutter MD, Lovat LB <a style=\"background-color: #ffffff;font-size: 1rem\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33713606\/\">Predicting endoscopic activity recovery in England after COVID-19: a national analysis. <\/a><span style=\"font-weight: 400\">\u00a0<\/span><i style=\"font-size: 1rem\">Lancet Gastroenterol Hepato<\/i><span style=\"font-weight: 400\">l. 2021; 6:381-390<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Mark Lawler, Chris Carrigan, and colleagues describe how DATA-CAN\u2019s co-created partnership has brought together patient representatives, healthcare professionals, and academic and industry researchers to facilitate responsible collection and use of [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":419,"featured_media":50809,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18887],"tags":[],"class_list":["post-50807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnership-in-practice"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ\" \/>\n<meta property=\"og:description\" content=\"Mark Lawler, Chris Carrigan, and colleagues describe how DATA-CAN\u2019s co-created partnership has brought together patient representatives, healthcare professionals, and academic and industry researchers to facilitate responsible collection and use of [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T08:56:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-12T14:56:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kellybrendel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kellybrendel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/\"},\"author\":{\"name\":\"kellybrendel\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/d634d72476ce60014b19ed2db4ae3760\"},\"headline\":\"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value\",\"datePublished\":\"2021-08-11T08:56:45+00:00\",\"dateModified\":\"2021-08-12T14:56:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/\"},\"wordCount\":2522,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/08\\\/woman_cancer_talking_iStock-1176678050.jpg\",\"articleSection\":[\"Partnership in practice\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/\",\"name\":\"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/08\\\/woman_cancer_talking_iStock-1176678050.jpg\",\"datePublished\":\"2021-08-11T08:56:45+00:00\",\"dateModified\":\"2021-08-12T14:56:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/08\\\/woman_cancer_talking_iStock-1176678050.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/08\\\/woman_cancer_talking_iStock-1176678050.jpg\",\"width\":540,\"height\":350,\"caption\":\"An Asian woman with cancer is consulting her doctor. The two women are seated at a table together. The patient is wearing a bandana to hide her hair loss. The medical professional is showing the patient test results on a digital tablet. They are discussing a treatment plan.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/08\\\/11\\\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/d634d72476ce60014b19ed2db4ae3760\",\"name\":\"kellybrendel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"caption\":\"kellybrendel\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/kellybrendel\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/","og_locale":"en_US","og_type":"article","og_title":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ","og_description":"Mark Lawler, Chris Carrigan, and colleagues describe how DATA-CAN\u2019s co-created partnership has brought together patient representatives, healthcare professionals, and academic and industry researchers to facilitate responsible collection and use of [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2021-08-11T08:56:45+00:00","article_modified_time":"2021-08-12T14:56:32+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg","type":"image\/jpeg"}],"author":"kellybrendel","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"kellybrendel","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/"},"author":{"name":"kellybrendel","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/d634d72476ce60014b19ed2db4ae3760"},"headline":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value","datePublished":"2021-08-11T08:56:45+00:00","dateModified":"2021-08-12T14:56:32+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/"},"wordCount":2522,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg","articleSection":["Partnership in practice"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/","url":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/","name":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg","datePublished":"2021-08-11T08:56:45+00:00","dateModified":"2021-08-12T14:56:32+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/08\/woman_cancer_talking_iStock-1176678050.jpg","width":540,"height":350,"caption":"An Asian woman with cancer is consulting her doctor. The two women are seated at a table together. The patient is wearing a bandana to hide her hair loss. The medical professional is showing the patient test results on a digital tablet. They are discussing a treatment plan."},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/08\/11\/data-can-a-co-created-cancer-data-knowledge-network-to-deliver-better-outcomes-and-higher-societal-value\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"DATA-CAN: a co-created cancer data knowledge network to deliver better outcomes and higher societal value"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/d634d72476ce60014b19ed2db4ae3760","name":"kellybrendel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","caption":"kellybrendel"},"url":"https:\/\/blogs.bmj.com\/bmj\/author\/kellybrendel\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/50807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/419"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=50807"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/50807\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/50809"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=50807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=50807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=50807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}